Expanding Demand Across Hormonal Health: Market Outlook The Europe Hormone Replacement Therapy (HRT) market continues on a ...

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), in its latest drug safety alert, ...

Kaushik Basu, ex-World Bank chief economist, finds the US's new reciprocal tariff of 26% on India baffling, arguing it will ...

Penny stocks tend to be considered high-risk, high-return stocks, and they are attractive options for investors who are ...